Literature DB >> 3500736

Effect of oral administration of a new calcium channel blocking agent, bepridil on antipyrine clearance in man.

C Funck-Brentano1, P L Chaffin, G R Wilkinson, B McAllister, R L Woosley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3500736      PMCID： PMC1386322          DOI： 10.1111/j.1365-2125.1987.tb03213.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.

Authors:  M W Teunissen; J E Meerburg-van der Torren; N P Vermeulen; D D Breimer
Journal:  J Chromatogr       Date:  1983-12-09

3.  Effect of bepridil on the activity of cytochrome c oxidase in solution and in proteoliposomes.

Authors:  E Antonini; M Brunori; A Colosimo; P Sarti
Journal:  Biochem Pharmacol       Date:  1984-01-01       Impact factor: 5.858

4.  The effect of oral verapamil therapy on antipyrine clearance.

Authors:  D O Rumiantsev; V K Piotrovskii; O S Riabokon; I D Slastnikova; E V Kokurina; V I Metelitsa
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

5.  Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.

Authors:  L A Bauer; M Stenwall; J R Horn; R Davis; K Opheim; L Greene
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875
  5 in total
  1 in total

1.  An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.

Authors:  T Edeki; A Johnston; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.